BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31694814)

  • 1. Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.
    Mofors J; Björk A; Smedby KE; Kvarnström M; Forsblad-d'Elia H; Magnusson-Bucher S; Eriksson P; Mandl T; Baecklund E; Nordmark G; Wahren-Herlenius M
    Ann Rheum Dis; 2020 Feb; 79(2):307-308. PubMed ID: 31694814
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.
    Ben-Chetrit E; Fischel R; Rubinow A
    Clin Rheumatol; 1993 Dec; 12(4):471-4. PubMed ID: 8124907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.
    Mofors J; Holmqvist M; Westermark L; Björk A; Kvarnström M; Forsblad-d'Elia H; Magnusson Bucher S; Eriksson P; Theander E; Mandl T; Wahren-Herlenius M; Nordmark G
    J Intern Med; 2019 Oct; 286(4):458-468. PubMed ID: 31127862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
    Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjögren's syndrome.
    Salomonsson S; Wahren-Herlenius M
    Scand J Rheumatol; 2003; 32(2):79-82. PubMed ID: 12737325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of antiperinuclear factor in primary Sjogren's syndrome].
    Varshavskaia AA; Shilkina NP; Baranov AA; Makarushin AA
    Klin Lab Diagn; 2000 Jan; (1):35-7. PubMed ID: 10878900
    [No Abstract]   [Full Text] [Related]  

  • 10. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
    Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
    J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active immunological profile in patients with primary Sjögren's syndrome is restricted to typically encountered autoantibodies.
    Capaldo C; Carvajal Alegria G; Cornec D; Jousse-Joulin S; Devauchelle-Pensec V; Renaudineau Y
    Clin Exp Rheumatol; 2016; 34(4):722. PubMed ID: 27191916
    [No Abstract]   [Full Text] [Related]  

  • 13. End-stage renal failure in adolescence with Sjögren's syndrome autoantibodies SSA and SSB.
    Johnson S; Hulton SA; Brundler MA; Moss C; Huissoon A; Taylor CM
    Pediatr Nephrol; 2007 Oct; 22(10):1793-7. PubMed ID: 17636342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
    ter Borg EJ; Risselada AP; Kelder JC
    Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
    Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
    Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
    [No Abstract]   [Full Text] [Related]  

  • 17. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
    Ter Borg EJ; Kelder JC
    Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.
    Pourmand N; Wahren-Herlenius M; Gunnarsson I; Svenungsson E; Löfström B; Ioannou Y; Isenberg DA; Magnusson CG
    Ann Rheum Dis; 1999 Oct; 58(10):623-9. PubMed ID: 10491361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease?
    Danda D; Sharma R; Truong D; Koelsch KA; Kurien BT; Bagavant H; Deshmukh U; Kaufman CE; Lewis DM; Stone DU; Radfar L; Rasmussen A; Sivils KL; Scofield RH
    Clin Exp Rheumatol; 2017; 35(3):438-444. PubMed ID: 28229827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.